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Background: Rutin is an important flavonoid that is consumed in the daily diet. The cytoprotective effects of rutin,
including antioxidative, and neuroprotective have been shown in several studies. Neurotoxic effects of acrylamide
(ACR) have been established in humans and animals. In this study, the protective effects of rutin in prevention and
treatment of neural toxicity of ACR were studied.
Results: Rutin significantly reduced cell death induced by ACR (5.46 mM) in time- and dose-dependent manners.
Rutin treatment decreased the ACR-induced cytotoxicity significantly in comparison to control (P <0.01, P < 0.001).
Rutin (100 and 200 mg/kg) could prevent decrease of body weight in rats. In combination treatments with rutin
(50, 100 and 200 mg/kg), vitamin E (200 mg/kg) and ACR, gait abnormalities significantly decreased in a dose-
dependent manner (P < 0.01 and P < 0.001). The level of malondialdehyde significantly decreased in the brain tissue
of rats in both preventive and therapeutic groups that received rutin (100 and 200 mg/kg).
Conclusion: It seems that rutin could be effective in reducing neurotoxicity and the neuroprotective effect of it
might be mediated via antioxidant activity.
Keywords: Rutin, Acrylamide, MTT assay, Neural toxicity, AntioxidantIntroduction
Risk factors in food are either of chemical or microbio-
logical origin, or a combination of both. Acrylamide
(ACR), one such risk factor, is a possible human carcino-
gen [1]. It is an industrial chemical and has been known
as an occupational hazard for decades [2,3]. However, in
recent years, ACR has been found to form in fried and
baked starchy foods during cooking [4,5]. This latter
finding has greatly raised public concerns over ACR’s
potential health risk due to dietary exposure to people.
ACR is a neurotoxic chemical and can cause peripheral
and central neuropathy in humans and laboratory ani-
mals [6].
Early morphological studies suggested that both hu-
man and experimental neurotoxicities were mediated
by cerebellar Purkinje cell injury and by degeneration
of distal axons in the peripheral (PNS) and central ner-
vous system (CNS) [7]. In addition to neurotoxicity,* Correspondence: hosseinzadehh@mums.ac.ir
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distribution, and reproduction in any mediumconsiderable experimental data from rodent studies has
shown that ACR induces reproductive toxicity (e.g. re-
duced litter size) and genotoxic effects (e.g. DNA strand
breaks, dominant lethal mutation) [3,8,9]. There are sev-
eral reports that antioxidant agents could rescue neuro-
toxicity induced by ACR via increasing antioxidant
activity [10-14].
Rutin (3, 3′, 4′, 5, 7 -pentahydroxyflavone-3-rhamno-
glucoside) is a flavonoid of the flavonol type that is
found in many typical plants, such as buckwheat, pas-
sion flower, apple and tea. It is also an important dietary
constituent of foods and plant-based beverages [15].
Rutin has several pharmacological properties, including
antioxidant, anticarcinogenic, cytoprotective, vasoprotec-
tive, cardioprotective and neuroprotective activities
[16-23]. In humans, it attaches to the iron ion (Fe), pre-
venting it from binding to hydrogen peroxide, which
would otherwise create a highly reactive free radical that
may damage cells [24].
The present study was therefore designed to investi-
gate the protective effects of rutin in prevention and
treatment of neural toxicity induced by ACR.d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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Materials
RPMI 1640 and FBS were purchased from Gibco. (4,5-
dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium (MTT),
rutin hydrate ≥94% (HPLC), TBA (2-thiobarbituric acid),
n-butanol, potassium chloride, phosphoric acid and ACR
were obtained from Merck. Vitamin E was purchased in
injectable form from Osveh Company, Iran.
Cell culture
PC12 cells were obtained from Pasteur Institute (Tehran,
Iran). Cells were maintained at 37°C in a humidified at-
mosphere (90%) containing 5% CO2. Cells were grown in
RPMI 1640 medium supplemented with 10% (v/v) heat-
inactivated foetal bovine serum, 100 U/ml penicillin and
100 μg /ml streptomycin.
Cell viability
The viability of cultured cells was determined by assaying
the reduction of 3-(4,5-dimethyl thiazol-2-yl)-2,5- diphe-
nyl tetrazolium bromide (MTT) to formazan [25]. Briefly,
PC12 cells were cultured in a 96-well microliter plate at a
density of 5000 cell/well. After pretreatment with rutin
(0.5, 1, 1.5, 2.5, 5, 10, 20, 40, 80 and 160 μM/ml) for 24 h,
ACR at concentration of 5.46 mM was added to each well.
The cells were then incubated for 48 h and then treated
with MTT solution (0.5 mg/ml PBS) for 1 h at 37°C.
Upper mediate replaced with dimethyl sulfoxide (DMSO).
The absorbance was measured at 570 nm (630 nm as ref-
erence) in a plate reader (TECAN infinit M200) [14].
Experimental animals
Male Wistar rats (200–270 g) were housed in colony
rooms with 12/12 h light/dark cycle at 21 ± 2°C and had
free access to food and water. All animal experiments
were carried out in accordance with Mashhad University
of Medical Sciences, Ethical committee Acts.
Experimental design
To induce neurotoxicity in rats, the animals were ex-
posed to ACR at a daily dose of 50 mg/kg intraperitone-
ally (i.p.) [26]. All doses of rutin were selected as our
previous work [18]. This daily dose and the correspond-
ing route have been well characterized with respect to
neuropathological expression and neurological deficits.
For our study on the preventive effect, the rats were di-
vided at random into 7 groups (n = 6 in each group) and
treatment was given as follows:
1) Saline (negative control) for 14 days
2) ACR (50 mg/kg, i.p.) for 14 days
3) Rutin (50 mg/kg, i.p.) for 3 days alone and afterward
rutin (50 mg/kg, i.p.) + ACR (50 mg/kg, i.p.) for
11 days4) Rutin (100 mg/kg, i.p.) for 3 days alone and afterward
rutin (100 mg/kg, i.p.) +ACR (50 mg/kg, i.p.) for 11 days
5) Rutin (200 mg/kg, i.p.) for 3 days alone and afterward
rutin (200 mg/kg, i.p.) +ACR (50 mg/kg, i.p.) for 11 days
6) Rutin (200 mg/kg, i.p.) for 14 days
7) Vitamin E (200 mg/kg, i.p.) (positive control) for
3 days alone and afterward vitamin E (200 mg/kg,
i.p.) + ACR (50 mg/kg, i.p.) for 11 days
Behavioural testing to assess preventive effects was
performed on the 15th day [14].
After studying doses of rutin in preventing neurotox-
icity, the most effective dose was used to assess its thera-
peutic effect. For our study, the rats were divided at
random into 5 groups (n = 6 in each group) and treat-
ment was given as follows:
1) Normal saline (negative control) for 14 days
2) ACR (50 mg/kg, i.p.) for 3 days alone and afterward
ACR (50 mg/kg, i.p.) + rutin (200 mg/kg, i.p.) for 11 days
3) ACR (50 mg/kg, i.p.) for 3 days alone and afterward
ACR (50 mg/kg, i.p.) + vitamin E (200 mg/kg, i.p.)
for 11 days
4) ACR (50 mg/kg i.p.) for 7 days alone and afterward
ACR (50 mg/kg, i.p.) + rutin (200 mg/kg i.p.) for 7 days
5) ACR (50 mg/kg i.p.) for 7 days alone and afterward
ACR (50 mg/kg, i.p.) + vitamin E (200 mg/kg, i.p.)
for 7 days
Behavioural testing was performed on the 15th day [14].
The behavioural index (gait scores) examination
After completion of treatment, the rats were placed in a
clear plexiglass box and were observed for 3 min. Fol-
lowing observation, a gait score was assigned from 1 to
4, where 1 = a normal, unaffected gait; 2 = a slightly af-
fected gait (foot splay, slight hind limb weakness and
spread); 3 = a moderately affected gait (foot splay, mod-
erate hind limb weakness, moderate limb spread during
ambulation) and 4 = a severely affected gait (foot splay,
severe hind limb weakness, dragging hind limbs, inability
to rear) [27].
Biochemical assay
Furthermore, a test was conducted to determine lipid
peroxidation by determining thiobarbituric acid reactive
products (TBAR) of lipid peroxidation in brain tissue of
rats [28,29]. Malondialdehyde (MDA) is the final prod-
uct of lipid peroxidation and its complex with TBA is
red and has maximum absorbance at 532 nm; MDA
was assessed as the lipid peroxidation indicator. Briefly,
the brain tissue was homogenized in cold KCl solution
(1.5%) to obtain a homogenous suspension (10%). To a
10-ml tube, 0.5 ml of suspension was poured and 3 ml
Figure 1 Cell viability of PC12 cells after exposure to different concentrations of acrylamide (ACR) for 24, 48 and 72 h. Cell viability was
determined by MTT test. Data are expressed as mean ± SEM of 6 separate experiments. ACR was solubilised in PBS. For control cells PBS was
used. ***P < 0.001 vs. control cells.
Figure 2 Effect of rutin on ACR-induced cytotoxicity in PC12 cells. Cells were pretreated with different concentration of rutin (0.5, 1, 1.5, 2.5,
5, 10, 20, 40, 80 and 160 μM/ml) for 24 h and ACR (5.46 mM) was added to each well later, followed by evaluation of cell viability using MTT
assay. Data are expressed as the mean ± SEM of 6 separate experiments (n = 6). **P < 0.01, ***P < 0.001 vs. ACR-treated cells.
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which the tube was placed in a boiling water bath for
45 min. Then, the suspension was cooled, 4 ml n-butanol
added and the tube placed in vortex for complex mixing
(1 min). Following this, the suspension was centrifuged
(20000 rpm speed, 20 minutes) to separate the red-
coloured upper phase and its absorbance was determined
using the spectrophotometer. The standard curve for
MDA (0–40 μM) was prepared [30].
Statistical analysis
Results are expressed as mean ± SEM. For in vitro assay,
IC50 values were calculated using the method described
by Litchfield and Wilcoxon method (PHARM/PCS soft-
ware version 4). Statistical analyses were performed with
ANOVA followed by the Tukey–Kramer test to compare
the differences between means. Differences were consid-
ered statistically significant when P < 0.05.
Results
Effect of ACR in PC12 cells
The PC12 cells were treated with different concentration
of ACR for 24, 48 and 72 h. Following this, the cellFigure 3 Protective effect of rutin (after 14 days of ACR exposure) by
expressed as mean ± SEM, (n = 6), **P < 0.01, ***P < 0.001 vs. first weight ofviability was measured using MTT test. Treatment of cells
with ACR decreased viability in time- and dose-dependent
manners, as shown in Figure 1. The IC50 (50% inhibitory
concentration) value for treatment of PC12 cells with
ACR for 48 h was 5.46 mM.Effect of rutin on ACR-induced cytotoxicity in PC12 cells
PC12 cells were treated with different concentrations of
rutin (0.5, 1, 1.5, 2.5, 5, 10, 20, 40, 80 and 160 μM/ml)
for 24 h and then ACR (5.46 mM) was added to each
well, followed by evaluation of cell viability using MTT
assay. Rutin treatment decreased the ACR-induced cyto-
toxicity significantly in comparison to control (Figure 2).Effect of ACR on rat body weight and the protective
effect of rutin
The body weight of the ACR group decreased 33.6%
after 14-day exposure to ACR (Figure 3). Treatment with
rutin at a dose of 50 mg/kg failed to prevent weight loss
caused by ACR. Therefore, body weight decreased after
14 days. However, rutin at doses of 100 and 200 mg/kg
prevented decrease of body weight in rats. Vitamin Ecomparison between the initial and end weight of rats. Data are
each group treated with drugs.
Figure 4 Therapeutic effect of rutin (after 14 days of ACR exposure) by comparison between the initial and end weight of rats.
Data are expressed as mean ± SEM, (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001 vs. first weight of each group treated with drugs.
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(Figure 3).
Effect of ACR on rat body weight and the therapeutic
effect of rutin
In the control group, only the body weight increased
after 14 days compared with the first weight (P < 0.01).
In other groups, the body weight significantly decreased
compared with the first weight. However, in the groupFigure 5 Protective effect of rutin on behavioural index (gait scores)
Data are expressed as the mean ± SEM, (n = 6). +++P < 0.001 vs. control, *Padministered vitamin E, there was no significant change
in body weight after 3 days (Figure 4).
Effect of ACR on the behavioural index (gait scores) in
rats and the protective effect of rutin
Exposure to ACR (50 mg/kg, i.p.) for 14 days led to pro-
gressive gait abnormalities in rats, as shown in Figure 5.
In groups of rats that were treated with combination of
rutin (50, 100 and 200 mg/kg), vitamin E (200 mg/kg)in rats during treatment with ACR (50 mg/ kg, i.p.) for 14 days.
< 0.05 **P < 0.01, ***P < 0.001 vs. ACR-treated animals.
Figure 6 Therapeutic effect of rutin on behavioural index (gait scores) in rats during treatment with ACR (50 mg/ kg, i.p.) for 14 days.
Data are expressed as the mean ± SEM, (n = 6). +++P < 0.001 vs. control, *P < 0.05 vs. ACR-treated animals.
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dose-dependent manner (P < 0.01 and P < 0.001 vs. ACR-
treated group) (Figure 5).
Effect of ACR on the behavioural index (gait scores) in
rats and the therapeutic effect of rutin
The groups in which the therapeutic effect of rutin were
evaluated, ACR was administered to the animals for 3
and 7 days and then treated 11 and 7 days with rutin
and vitamin E with combination of ACR, respectively. In
all groups, gait abnormalities decreased but the effect of
vitamin E was only significant compared with ACR after
3 days treatment (P < 0.05) (Figure 6).Table 1 Protective effect of rutin on lipid peroxidation
following ACR administration
Groups MDA concentration
(nmol/g) tissue
14 days Control 45.75 ± 3.92
14 days ACR 50 mg/kg 92.58 ± 3.69+++
14 days Rutin 200 mg/kg 75.52 ± 2.55***
3 days Rutin 50 mg/kg-11 days
(ACR 50 mg/kg + Rutin 50 mg/kg)
69.39 ± 4.26
3 days Rutin 100 mg/kg-11 days
(ACR 50 mg/kg + Rutin 100 mg/kg)
49.7 ± 7.77*
3 days Rutin 200 mg/kg-11 days
(ACR 50 mg/kg + Rutin 200 mg/kg)
47.76 ± 3.05***
3 days Vit E 200 mg/kg-11 days
(ACR 50 mg/kg + Vit E 200 mg/kg)
52.67 ± 4.38***
Values are mean ± SEM (n = 6). +++P < 0.001 vs. control, *P < 0.05, ***P < 0.001
vs. ACR-treated animals.Effect of rutin in biochemical assay
There was an increase in the MDA levels following
ACR administration compared with the control group
(P < 0.001). The MDA levels significantly reduced dose
dependently in all groups that were administrated rutin
for preventive and therapeutic purposes (except on ad-
ministration of 50 mg/kg rutin) (Tables 1 and 2).
Discussion
In this study, the neuroprotective effect of rutin on ACR-
induced cytotoxicity in PC12 cells and ACR-induced
neurotoxicity in rats was evaluated. Results showed that
ACR could decrease cell viability in PC12 cells, which wasTable 2 Therapeutic effect of rutin on lipid peroxidation
following ACR administration
Groups MDA concentration
(nmol/g) tissue
14 days Control 45.75 ± 3.92
14 days ACR 50 mg/kg 92.58 ± 3.69+++
3 days ACR 50 mg/kg-11 days
(ACR 50 mg/kg + Rutin 200 mg/kg)
65.10 ± 5.03**
3 days ACR 50 mg/kg-11 days
(ACR 50 mg/kg + Vit E 200 mg/kg)
60.75 ± 3.46***
7 days ACR 50 mg/kg-7 days
(ACR 50 mg/kg + Rurin 200 mg/kg)
69.67 ± 5.630*
7 days ACR 50 mg/kg-7 days
(ACR 50 mg/kg + Vit E 200 mg/kg)
68.87 ± 5.14*
Values are mean ± SEM (n = 6). +++P < 0.001 vs. control, *P < 0.05, **P < 0.01,
***P < 0.001 vs. ACR-treated animals.
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cantly inhibited behavioural index changes and body
weight loss caused by ACR administration in rats. Also, the
MDA levels significantly reduced in all groups of rutin.
ACR is known to induce apoptosis in time- and dose-
dependent manners in neurons and astrocytes and sig-
nificantly reduce the proliferation of neural progenitor
cells and, in high concentrations [31]. In our study, ACR
(5.46 mM) decreased cell viability in PC12 cells and pre-
treatment with rutin (0.5, 1, 1.5, 2.5, 5, 10, 20 and
40 μM/ml) increased the cell viability. According to pre-
vious studies, reactive oxygen species (ROS) have im-
portant role in the toxicity of ACR [31,32].
Antioxidant effects of rutin have been established in
several studies [23,33]. Rutin and catechol-compounds
are electron donors, and antioxidant activities of rutin
and catechol and its derivatives indicate that they are
potential antioxidants [34,35]. It seems that the protect-
ive effect of rutin in this model may be at least, in part,
due to suppression of ROS generation because rutin has
exhibited antioxidant effect in different studies [36].
ACR monomer is a potent neurotoxin and capable of
inducing CNS and PNS damages in humans and ani-
mals. ACR induces ataxia, skeletal muscle weakness and
weight loss in both occupationally exposed humans and
experimental animal models [26,37]. Our results showed
that treatment of animals with ACR (50 mg/kg, i.p.) for
11 days decreased body weight and caused gait abnor-
malities, and at the end of 14 days, ACR-exposed ani-
mals displayed severe abnormal gait (scores 4), but
treatment of animals with rutin prevented the decrease
in body weight and reduced abnormal gait.
In recent decades, there are several studies that have
shown the neuroprotective effects of rutin [38-40]. Rutin
has neuroprotective effect in brain ischemia and its ad-
ministration attenuates ischemic neural apoptosis by in-
hibition of neurological deficit, lipid peroxidation, p53
expression and increase in endogenous antioxidant de-
fence enzymes [41]. It was shown that the 4-oxo group
and the 2,3 double bond in the C ring are common in
rutin and that it may be related by its neuroprotective
action [42]. Rutin has beneficial effects on hypoxic, glu-
tamate and oxidative stress at concentrations as low as 1
nM on retinal ganglion cell. It appears that the sugar
side chain of flavonoids may be important for neuropro-
tective activities [43].
The neuroprotective effect of vitamin E is related to
its antioxidant activity [44,45]. For this reason, vitamin E
was used was as a positive control in protection against
ACR- induced neurotoxicity. As our results, vitamin E
(200 mg/kg) increased the body weight compared to
rutin as a preventive agent in rats.
It seems that the effect of vitamin E in the presence
of ACR after 3 days treatment in inhibition of gaitabnormalities is more than rutin (200 mg/kg). However,
the protective and therapeutic effects of rutin (200 mg/kg)
on lipid peroxidation following ACR administration are
same as vitamin E (200 mg/kg).
It is possible that rutin by inhibiting neurological def-
icit could improve behavioral index of animals. More-
over, it was shown that rutin might be effective in
treatment of tardive dyskinesia, an extrapyramidal move-
ment disorder, through communicating the imbalance of
dopaminergic transmission [46]. Pretreatment of rutin
(100 and 200 mg/kg/day) for long-term caused behav-
ioural and neurochemical changes in aged WAG male
rats. It is possible that rutin may exert this effect by af-
fecting brain dopaminergic and adrenergic systems [47].
Thus, there is another possibility that rutin could im-
prove behavioral index of animals via modulating dopa-
minergic and adrenergic transmissions.
The results of the current study suggested that pro-
tective effect of rutin against ACR cytotoxicity in PC12
cells and rats was due to inhibition of ROS production
in PC12 cells exposed to ACR or in the rat nervous sys-
tem under ACR treatment.
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